EcoDrugPlus

Integrin Subunit Alpha 4

Ensembl ID : ENSLCRG00005017949
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSLCRG00005012965
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSLCRG00005001971
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSLCRG00005011773
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSLCRG00005022206
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSLCRG00005007326
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSLCRG00005011236
Gene Symbol: ITGAV
3 Cross references
237 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSLCRG00005023903
Gene Symbol: ITGB1A
3 Cross references
199 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSLCRG00005018299
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSLCRG00005018744
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSLCRG00005004740
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSLCRG00005021227
Gene Symbol: IDH2
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).